Related Experiment Video
Updated: May 2, 2026
07:54
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
Published on: March 31, 2021
4.6K
Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases
1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Chinese Academy of Sciences (CAS), Beijing 100190, China.
Molecules (Basel, Switzerland)
|April 13, 2024
Summary
Rapid nucleic acid diagnostic technologies are crucial for controlling pandemic spread and ensuring timely patient treatment. This review covers current methods in rapid extraction, amplification, and detection, exploring future advancements in pandemic disease diagnosis.
Area of Science:
- Clinical diagnostics
- Molecular biology
- Pandemic preparedness
Background:
- The COVID-19 pandemic highlighted the critical need for rapid diagnostic solutions.
- Timely diagnosis is essential for controlling infectious disease spread and enabling prompt patient care.
- Existing diagnostic methods often lack the speed required for effective population-level screening during outbreaks.
Purpose of the Study:
- To review and summarize current rapid nucleic acid diagnostic technologies for pandemic diseases.
- To provide an overview of advancements in rapid nucleic acid extraction, amplification, and detection.
- To discuss the future trajectory of rapid nucleic acid diagnostic technology development.
Main Methods:
- Literature review of recent advancements in rapid nucleic acid diagnostics.
- Categorization of technologies based on workflow stages: extraction, amplification, and detection.
- Analysis of current trends and future research directions in the field.
Main Results:
- Significant progress has been made in developing rapid nucleic acid-based diagnostic platforms.
- Key innovations focus on streamlining sample preparation, accelerating amplification, and enabling faster detection.
- Integrated systems combining multiple steps are emerging for enhanced efficiency.
Conclusions:
- Rapid nucleic acid diagnostics are vital for effective pandemic response and management.
- Continued innovation is expected to further improve speed, sensitivity, and accessibility of these tests.
- Future developments will likely focus on point-of-care applications and multiplexed detection capabilities.
